Previous studies have shown that HNK can alleviate lipid metabolism disorders of NASH by suppressing the expression of SREBP-1c, FAS, SCD-1 and promoting the phosphorylation of ACC, which are the key genes involved in fatty acid and unsaturated fatty acid biosynthesis pathways11–13. Here, SREBF1 is linked to metabolic dysfunction-associated steatohepatitis.